Iovance Biotherapeutics, Inc.

US$8.04As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IOVAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 2.55%
Div yield —
ROE (29.11%)
Biotechnology
Beta (5Y) 0.84
PE TTM —
TSR TTM 308.12%
Mkt cap US$3.720B
ROIC (17.86%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.42
4.70%
(56.12%)
Hold 6|6|5|6|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.17
0.17
0.19
0.19
9.52%
14.19%
15.77%
19.97%
Revenue$M
191.1
200.4
195.0
200.0
10.44%
14.87%
11.23%
8.24%
Peers (US$3.720B)
Cap (US$)
PE
3.756B
35.19x
Capital
TTM
5Y
10Y
Leveragex
4.392
(0.016)
(0.015)
EBIT/Intx
5.046
0.096
0.101
Own earn%
16.08
150.40
154.01
Sh yield%
30.90
65.65
61.09
Owners
Insiders/Inst%
2.87
59.26
Short interest%
1.43
SBC / revenue%
3.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
17–24
$1 testx
0.2
Incr. ROIC%
10